Adam Ang
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.
The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.
HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.
Screening rates in northern Queensland lag behind the statewide average.
The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.
It shows potential for early, opportunistic screening for osteoporosis without a separate bone density test, according to Seoul National University Hospital researchers.
The Korean AI company also plans expansion into Vietnam and Hong Kong.